Concepedia

Wenxin Kou

WK

14

Publications

477

Citations

12

H-Index

2017

Active since

Affiliations

Tongji University(Current)

Shanghai Tenth People's Hospital

XinHua Hospital

Brigham and Women's Hospital

Harvard University

Wenxin Kou is an author at Tongji University specializing in cell signaling, inflammation, and medicine.

ORCID

Top concepts

Publications per year

2017–2023

14

Publications

14

FNDC5/Irisin inhibits pathological cardiac hypertrophy

Qing Yu, Wenxin Kou, Xu Xu et al. · Clinical Science · 2019 · 111 citations

NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation

Peipei Luan, Jianhui Zhuang, Jun Zou et al. · The FASEB Journal · 2017 · 61 citations · Full text

Extracellular traps from activated vascular smooth muscle cells drive the progression of atherosclerosis

Ming Zhai, Shiyu Gong, Peipei Luan et al. · Nature Communications · 2022 · 48 citations · Full text

NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ

Peipei Luan, Weixia Jian, Xu Xu et al. · Nature Communications · 2019 · 44 citations · Full text

, , +26

The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease

Bo Li, Zhijun Lei, You Wu et al. · Frontiers in Cardiovascular Medicine · 2021 · 31 citations · Full text

Rows per page

1–5 of 14